Proliferative Diabetic Retinopathy
📧 Sign up to get email alerts when something new happens for Proliferative Diabetic Retinopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population [Phase 3]
A Phase 3 clinical trial investigating HLA and its relation to the development of proliferative diabetic retinopathy in Mexican patients wit…
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Changes in Vitreous Temperature During Phacoemulsification [NA]
The clinical trial examining vitreous temperature changes during phacoemulsification for proliferative diabetic retinopathy has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy [Phase 2, Phase 3]
A clinical trial comparing intravitreal bevacizumab with photocoagulation for proliferative diabetic retinopathy has been withdrawn (Phase 2…
-
CLINICAL_TRIALS withdrawal · 2014-03-05Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy [Phase 3]
Phase 3 trial of intravitreal pegaptanib sodium (Macugen) versus sham for tractional retinal detachment and vitreous hemorrhage in prolifera…